A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Immune-associated genes are critical in thyroid carcinoma recurrence and metastasis.
• A validated prognostic signature for thyroid cancer is currently lacking.
• This study aimed to develop and evaluate a novel immune-related prognostic signature for thyroid cancer.

Purpose of the Study:

• To construct a novel immune-related prognostic signature for thyroid cancer.
• To evaluate the prognostic value of the developed signature using bioinformatics analysis.
• To explore the correlation between key immune-associated genes and clinical/immune factors in thyroid cancer.

Main Methods:

• Differential expression analysis of immune-associated genes from The Cancer Genome Atlas (TCGA) database.
• Development of a prognostic signature using least absolute shrinkage and selection operator (LASSO) and Cox regression analysis.
• Validation of the signature using survival curves, receiver-operator characteristic (ROC) curves, and independent prognostic analysis.

Main Results:

• A 5-gene signature including C-X-C motif chemokine ligand 5 (CXCL5), Azurocidin 1 (AZU1), nucleotide binding oligomerization domain containing 1 (NOD1), TNF Receptor Superfamily Member 11b (TNFRSF11B), and VGF nerve growth factor inducible (VGF) was developed.
• The signature demonstrated significant predictive value in both training and testing datasets.
• Correlation analyses suggested that the identified genes are involved in tumor immune infiltration and progression.

Conclusions:

• A novel 5-immune-associated gene signature for predicting thyroid cancer prognosis was successfully constructed.
• This signature holds potential for clinical application in evaluating individualized therapy and prognosis for thyroid cancer patients.
• Further research can explore the specific mechanisms of these genes in thyroid cancer progression and immune response.